Clinical Effectiveness of Spironolactone in Hospitalized Older Eligible (EF Less Than or Equal to 35% and eGFR Greater Than or Equal to 30 mL/Min/1.73 m2) Patients With Heart Failure
Document Type
Abstract
Publication Date
March 2017
Journal Title
Journal of the American College of Cardiology
Department
Medicine
Recommended Citation
Dooley, D., Lam, P., Bayoumi, E., Segal, J., Arundel, C., Filppatos, G., Butler, J., Deedwania, P., White, M., Blackman, M., Morgan, C., Deftereos, S., Aronow, W. S., Anker, S., Pitt, B., Fonarow, G., & Ahmed, A. (2017). Clinical Effectiveness of Spironolactone in Hospitalized Older Eligible (EF Less Than or Equal to 35% and eGFR Greater Than or Equal to 30 mL/Min/1.73 m2) Patients With Heart Failure. Journal of the American College of Cardiology, 69 (11 Suppl.), 914. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/28
COinS
